SODIUM POLYSTYRENE SULFONATE
Generic: SODIUM POLYSTYRENE SULFONATE
Chartwell RXManufacturer
ORAL, RECTALRoute
SODIUM POLYSTYRENE SULFONATEActive Substance
2016-02-18Original Approval
SODIUM POLYSTYRENE SULFONATE is FDA application ANDA206815, sponsored by CHARTWELL RX. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
HYPERKALAEMIA
103 reports
2
DIARRHOEA
82 reports
3
ACUTE KIDNEY INJURY
68 reports
4
FATIGUE
60 reports
5
RENAL FAILURE
57 reports
6
NAUSEA
56 reports
7
CONSTIPATION
55 reports
8
DRUG INTERACTION
54 reports
9
VOMITING
52 reports
10
DEATH
49 reports